Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Everyone has probably dealt with at least a little physical pain in their life.But fortunately, the number of peop ...

(THE CONVERSATION) Chronic pain affects hundreds of millions of people around the world. But the opioid crisis in North America led many health care providers to realize they relied too heavily on ...

What Happened: After conducting a thorough analysis, LUDWIG sold 12,000 shares of Boston Scientific. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission ...

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Patients can now receive interventional techniques that are no longer palliative in nature,” stated Samir Khan, DO, provider ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Spinal Cord Stimulators Market. The global spinal cord stimulators market is on an accelerated growth path, projected to ...

A study on older adults in long-term care communities who experience pain found that it is linked to sleep quality and care dependency. That is, more severe pain is associated with poorer sleep ...

"Neuromodulation using gene therapy is an exciting new area that has wide-spread applications in treating not only chronic pain but other serious undertreated neurological disorders. We are delighted ...

Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, focusing on innovative treatments. MISSION VIEJO, CALIFORNIA / ACCESS Newswire / ...